For the millions living with inflammatory bowel disease, the question of why once-tolerated foods become sources of suffering has long gone unanswered. New research from McMaster University now traces a biological chain: gut inflammation depletes the specific bacteria that digest foods like dairy and gluten, and in their absence, the immune system begins treating familiar foods as threats. The discovery reframes food sensitivity not as a fixed condition but as a consequence of microbial disruption — one that may, in time, be reversed.
Gut Inflammation Disrupts Bacteria That Process Food, Triggering IBD Sensitivities
IBD patients experience significant dietary restrictions and food-related symptoms affecting quality of life, with about two-thirds reporting adverse reactions to common foods.
Inflammation depletes the bacteria that process food, not the foods themselves.
Mark
So the study shows that inflammation damages the bacteria that digest certain foods. But how do we know it's the bacteria doing the work and not just the inflammation itself making the gut sensitive?
Mimi
That's exactly what the transfer experiment tested. When they moved bacteria from inflamed mice into germ-free mice with no inflammation, those healthy mice still developed the sensitivity. The bacteria alone was enough to transfer the problem.
Luke
But we should be careful here—that's a mouse model. The human data shows correlation: IBD patients with food intolerances have lower levels of these bacteria. That's not the same as proving causation in people the way the mouse experiments do.
Mark
Fair point. So in humans, we know the pattern exists, but we haven't proven the bacteria are causing it?
Mimi
Right. We see the association clearly. But the mouse work gives us a plausible mechanism that explains why the association might be causal.
Luke
And the researchers themselves say this is one piece of a larger picture—genetics, infections, stress all matter too. So even if we restore the bacteria, that might not solve everything for every patient.
Mark
That makes sense. So the next step would be testing whether actually restoring these bacteria in IBD patients reduces their food sensitivities?
Mimi
Exactly. That's where microbiome-based therapies come in. But that work hasn't been done yet in humans at this scale.
Luke
Which means patients shouldn't expect their gastroenterologist to prescribe a bacterial restoration therapy tomorrow. This is foundational science pointing toward a direction, not a treatment ready to deploy.
Mark
But it does explain why two-thirds of IBD patients have these problems, which is something we didn't have before.
Mimi
Yes. For years, people were told to avoid certain foods, but nobody could say why those foods suddenly became a problem. Now there's a biological story that makes sense.
Luke
As long as we remember it's a story supported by mouse data and human correlation, not yet human causation.
Le Pouls
- Two-thirds of IBD patients have reshaped their diets around food triggers they cannot fully explain, living under restrictions that science has struggled to justify.
- Inflammation acts as a silent saboteur — wiping out the bacterial species responsible for breaking down common foods, leaving the immune system to encounter them in an unrecognized form.
- Mouse studies revealed that transferring bacteria from inflamed guts into germ-free animals was enough to pass the sensitization along, while restoring the missing bacteria reversed it — implicating the microbiome as the driver, not a bystander.
- The same microbial fingerprint found in mice appeared in human IBD patients reporting food intolerances, lending the mechanism biological credibility beyond the laboratory.
- The findings reposition microbiome-based therapies as a concrete clinical target — raising the possibility that dietary restrictions born of inflammation need not be permanent.
For the millions living with inflammatory bowel disease, the question of why once-tolerated foods become sources of suffering has long gone unanswered. New research from McMaster University now traces a biological chain: gut inflammation depletes the specific bacteria that digest foods like dairy and gluten, and in their absence, the immune system begins treating familiar foods as threats. The discovery reframes food sensitivity not as a fixed condition but as a consequence of microbial disruption — one that may, in time, be reversed.
Two-thirds of people with inflammatory bowel disease report that certain foods make them sick — dairy, wheat, fiber — and most reshape their diets around these suspected triggers with little scientific explanation for why the restriction helps. A study forthcoming in Gastroenterology now offers a concrete answer: the problem lies not in the foods themselves, but in what inflammation does to the bacteria that process them.
The gut's microbial community performs digestive work that human enzymes cannot manage alone. When IBD flares, inflammation depletes the specific bacteria responsible for breaking down trigger foods. The foods remain unchanged; the microbes that handle them disappear. Meeting these foods in an altered landscape, the immune system responds as though they were threats.
Researchers at McMaster University, led by Alberto Caminero, traced this mechanism through two mouse models of colitis. Inflamed animals developed food sensitivities they had not previously shown, with dairy and gluten triggering allergic-type immune responses. In a revealing experiment, gut bacteria from inflamed mice were transferred into germ-free animals — and those recipients became more prone to the same sensitivities. When the missing bacteria were restored to inflamed mice, the sensitization diminished. The microbiota was not merely associated with food sensitivity; it was producing it.
The pattern held in human patients, where IBD sufferers reporting food intolerances showed both reduced capacity to break down trigger foods and lower levels of the bacteria responsible for that work. The researchers noted that microbial disruption is likely one piece of a larger puzzle involving genetics, infection, and stress — but the inflammation-bacteria-sensitivity chain is real, and it points toward a concrete intervention. If restoring the depleted bacteria can reduce sensitization, then the dietary restrictions that millions of IBD patients live under may not need to be permanent. The work ahead is translating that possibility into practice.
Two-thirds of people with inflammatory bowel disease report that certain foods make them sick. Dairy. Wheat. Fiber. The list varies from person to person, but the pattern is consistent enough that most IBD patients—those living with Crohn's disease or ulcerative colitis—reshape their diets around these suspected triggers, often with little scientific backing for why the restriction actually helps. A study forthcoming in Gastroenterology offers a concrete answer to a question that has shadowed IBD care for years: why do foods that once caused no problem suddenly become intolerable?
The answer lies not in the foods themselves, but in what happens to the bacteria living inside the gut when inflammation strikes. The trillions of microorganisms that inhabit the intestines perform essential work—they break down food components that human enzymes cannot process alone. When IBD flares up, inflammation disrupts this microbial workforce. Specific bacteria that normally digest dairy or gluten become depleted. The foods remain the same. The bacteria that handle them vanish. And the immune system, meeting these foods in a changed landscape, reacts as though they were threats.
Researchers at McMaster University Medical Centre, led by Alberto Caminero and colleagues including Bruna Barbosa, Neeraj Narula, and Premysl Bercik, traced this mechanism using two mouse models of colitis. They found that inflamed animals developed food sensitivities they had not previously shown. After inflammation, exposure to dairy or gluten triggered an allergic-type immune response in the colon. When those foods were reintroduced later, the animals showed heightened gut sensitivity and worsening colitis symptoms. The culprit was clear: inflammation had depleted the bacteria responsible for breaking down these foods.
The researchers then performed a striking experiment. They transferred gut bacteria from the inflamed mice into germ-free mice—animals with no microbiota of their own. Those recipient mice became more prone to sensitization to the same foods. Conversely, when the missing bacteria were restored to the inflamed mice, the sensitization effects diminished. A single variable—the presence or absence of specific bacterial species—shifted the outcome. The microbiota was not merely correlated with food sensitivity; it was driving it.
The pattern held in human patients. Among IBD sufferers who reported food intolerances, researchers found two consistent markers: a reduced capacity to break down common trigger foods and lower levels of the bacteria responsible for that digestive work. The mechanism that emerged from mouse studies appeared in people too, suggesting a genuine biological pathway rather than coincidence or misattribution.
Caminero and his team framed their findings carefully. Microbiota disruption, they noted, is likely one piece of a larger puzzle that also includes genetics, infections, and stress—all factors that warrant further investigation. The inflammation-bacteria-food sensitivity chain is real, but it does not stand alone. Still, the discovery opens a concrete avenue for intervention. If inflammation depletes the bacteria that process certain foods, then restoring those bacteria might reduce the sensitivities that plague IBD patients. Microbiome-based therapies—approaches that aim to rebuild or rebalance the gut bacterial community—move from theoretical possibility to clinical target.
For the millions of IBD patients who have narrowed their diets based on trial and error, often without knowing why certain foods became problems, this research offers something rare: a mechanistic explanation. It also suggests that the solution may not require permanent dietary restriction. If the bacteria can be restored, the foods might be tolerated again. The work ahead is to translate that possibility into practice.
Citations marquantes
Inflammation impairs the microbiota's digestive capacity, potentially contributing to adverse food reactions and opening new possibilities for microbiome-based therapies— Alberto Caminero, PhD, study author
Envie de l'histoire complète ?
Lire l'original sur News-Medical ↗
Science & Space